Please note that not all cases of disease or outbreaks are reported; some outbreaks may only be reported if they occur outside of the usual recognised risk area or season, or they have been reported in greater than usual numbers. See 'About Outbreaks' tab below for further detail.

For further information on red, amber and green alert categories, see About Outbreaks tab.

20 October 2025

HIV in Fiji

A 2025 United Nations report has highlighted the dangers of unsafe practices amongst injecting drug users in Fiji and the contribution this has made in fuelling the sharp rise of new HIV infections. There has been a 10-fold increase in people living with HIV in Fiji between 2014 (500 cases) and 2024 (5,900 cases). Preliminary data from the Ministry of Health for 2024 shows around half of those receiving antiretroviral therapy contracted HIV through sharing needles. Please see the NHS information for further details on HIV.

Take usual precautions
17 October 2025

Contaminated medicine in India

On 13 October 2025, the World Health Organization (WHO) published a Medical Product Alert about oral cold medicine in India contaminated with diethylene glycol (toxic to humans) linked to clusters of acute illness and deaths of children in India. These medicines are COLDRIF, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals and Shape Pharma. These contaminated oral liquid medicines named in this alert are unsafe, pose a significant risk and can cause severe, potentially life-threatening illness. Their use, especially in children, may result in serious injury or death. Please see WHO Medical Product Alert N°5/2025: Substandard (contaminated) oral liquid medicines for further details.

Take extra precautions
17 October 2025
Germany + North Rhine-Westphalia

Extensively drug-resistant gonorrhoeae in Germany

As of 9 October 2025, a total of four locally acquired cases of extensively drug-resistant (XDR) Neisseria gonorrhoea were reported in 2025. A strong molecular connection was confirmed between three of these cases. All infections occurred in heterosexual adults living in the same geographical region of Germany, with no recent history of travel abroad. These are the first known locally acquired XDR/MDR Neisseria gonorrhoea cases in Germany. Please see UKHSA guidance on gonorrhoea for further details.

Take usual precautions
17 October 2025
Laos + Savannahket

cVDPV1 in Laos

As of 16 October 2025, one circulating vaccine-derived poliovirus type 1 (cVDPV1) case was confirmed, with onset of paralysis on 3 September 2025, in Savannahket. This is the first case in Laos this year and is a new emergence. Please see our Topics in Brief article for further details on polio.

Take usual precautions
16 October 2025

Chikungunya in Pakistan

As of September 2025, over 1,000 suspected cases of chikungunya have been reported in Pakistan during 2025. An increase in case numbers was noted between 4 May and 21 June 2025. Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions
16 October 2025

Chikungunya in Somalia

An outbreak of chikungunya has been reported in Sool region, January – June 2025. A total of 488 suspected cases were recorded. Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions
16 October 2025

Chikungunya in Indonesia

As of 31 July 2025, a total of 3,608 confirmed chikungunya cases have been reported across 19 provinces of Indonesia during 2025. This represents on increase in case numbers compared to the same period in 2024 when 1,399 cases were recorded. Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions
16 October 2025

Chikungunya in Malaysia

As of 2 August 2025, a total of 40 chikungunya cases (no deaths) have been reported in Malaysia during 2025. Three separate clusters were detected and successfully contained indicating an effective public health response. Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions
16 October 2025

Chikungunya in Philippines

As of 16 August 2025, a total of 628 cases of chikungunya (including one death) have been reported in the Philippines since the start of 2025. Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions
16 October 2025

Chikungunya in Kenya

An outbreak of chikungunya has been reported in Mombasa County, June – July 2025. A total of 614 cases (97 confirmed) and no deaths were recorded. Please see our Topics in Brief article for further details on chikungunya.

1
Take usual precautions

NaTHNaC regularly review and update information on disease outbreaks and other health issues that may affect the UK traveller. You can search the information by disease or by country in our Outbreak Surveillance section.

The information comes from a wide variety of sources and can be used along with the Country Information section of our website where you will find recommendations on vaccines, malaria and other risks for each country (where relevant).

Please note that not all cases of disease or outbreaks are reported. In some countries, there may be limited surveillance and reporting processes in place so information can be difficult to obtain. Some diseases may only be reported if they occur outside of the usual recognised risk area or season, or they have been reported in greater than usual numbers. Outbreaks of those diseases included in the UK childhood vaccination programme are not usually reported unless the outbreak is unusual or unexpected.

The information presented in the disease surveillance reports is collated from a variety of sources, including government bodies, international organisations and the media. The verification status of each report is clearly indicated. Verified reports are confirmed by official sources. Some unverified reports are included to ensure timely dissemination of information and where possible we will try to substantiate these reports, although confirmation may not always be possible. Unverified reports may be subject to change, misreporting and may later prove to be unsubstantiated. They should not therefore be regarded as official.

Where available, a web link is provided to the original information source. We cannot accept responsibility for the sites to which it links, or for the information found on those sites. Linking to outside sites does not in any way imply endorsement of these sites. If you wish to use the following content for official purposes, please refer to the original sources of information.

Key to NaTHNaC alert level feature

LEVEL 1: GREEN
Take usual precautions
Follow standard protective measures, as recommended for this destination, disease or situation. Be aware that advice may change and check for updates.
LEVEL 2: AMBER
Take extra precautions
Follow any additional precautions recommended. Be alert and check regularly for changes in advice about this ongoing situation. Advice may be relevant for all travellers or apply to a specific group of travellers.
LEVEL 3: RED
FCDO advise against travel
The Foreign, Commonwealth & Development Office (FCDO) advise against travel on health grounds. This may mean avoiding non-essential travel, or all travel, follow the FCDO advice for details. Please note we do not report on FCDO safety and security alerts. Travellers should check the FCDO travel advisories for their destination for this information.

Alert categories are based on the situation at the time of publication. They will not be routinely updated unless outbreak information or a news item is updated.